BMD5 indicates British Male Doctors' Trial; HOT8, Hypertension Optimal Treatment Trial; PHS4, Physicians' Health Study; PPP9, Primary Prevention Project; TPT7, Thrombosis Prevention Trial. The result of the chi-square test for heterogeneity was 5.36 (P=0.25).